Font Size

Pharmacy and Therapeutics Committee

Pharmacy and Therapeutics Committee Board members pictured: (front row) Deborah Minor, Pharm.D.; Louise Turman, Pharm.D.; Wilma Wilbanks, R.Ph. (Chair); Clyde Glenn, M.D.; Geri Weiland, M.D.; Karen Maltby, M.D.; (back row) Brad Gilchrist, Pharm.D.; Spencer Sullivan, M.D.; Stanley Hartness, M.D.; and, Kim Rodgers, R.Ph. (Not pictured: Benjamin Brock, M.D. and Caleb Williamson, Pharm.D.)

P&T Committee Overview

The Mississippi Division of Medicaid’s Pharmacy and Therapeutics (P&T) Committee is comprised of twelve participating physicians, nurse practitioners, and practicing pharmacists who are active MS Medicaid providers and in good standing with their representative organizations. The P&T Committee is an advisory panel who conducts in-depth clinical evaluations and recommends appropriate drugs for preferred status on DOM’s Preferred Drug List (PDL) and/or drugs for prior authorization. Drugs and drug classes are evaluated for their safety, efficacy, and overall cost value and the committee will make subsequent recommendations to the Executive Director regarding prior authorization criteria for these drugs and classes.

The decision of the committee regarding any limitations to be imposed on any drug or its use for a specified indication shall be based on sound clinical evidence found in labeling, drug compendia, and peer reviewed clinical literature pertaining to use of the drug in the relevant population.


P&T Committee Meeting Information

ATTENTION: Due to ongoing renovations in the Woolfolk Building, the P&T meetings scheduled for August and October of 2024 will be held at Table 100, located at 100 Ridge Way, Flowood, MS 39232.

The P&T Committee meets four (4) times annually.

Registration is requested for all pharmaceutical industry and advocacy representatives planning to attend a P&T Committee meeting in person. Registration opens 30 days prior to the meeting date. The Division also offers a Live Broadcast virtual meeting option. No registration is requested to log into the Live Broadcast. Please see the link below.

This meeting may be viewed virtually by clicking on the following link: Click Here for MS Medicaid P&T Live Broadcast on August 13, 2024 at 10:00 a.m.

Please note: This link will only be live during the meeting and will not be archived for future viewing.


P&T Committee Meeting Resources


Medicaid’s Pharmacy & Therapeutics Committee meeting schedule:

2024 P&T dates:

  • February 13, 2024
  • May 14, 2024
  • August 13, 2024
  • October 22, 2024

All meetings will be live with no virtual options.



P&T Committee Meeting Minutes and AgendasArchive of Meeting Minutes and Agendas

Date P&T Meeting Minutes Meeting Agenda
August 13, 2024 Minutes Agenda
May 14, 2024 Minutes Agenda
February 13, 2024 Minutes Agenda
October 24, 2023 Minutes Agenda
August 8, 2023 Minutes Agenda
May 9, 2023 Minutes Agenda


Important Information for Drug Manufacturers
MedImpact (MI), has been awarded the contract for Preferred Drug List Maintenance and Supplemental Rebate Program for the Mississippi Division of Medicaid (DOM) effective July 1, 2023.

Attn: GPS Medicaid Rebate Operations
10181 Scripps Gateway Ct.
San Diego, CA 92131

Industry Information Requests
Industry representatives with clinical inquires related to drugs listed on the Preferred Drug List may contact the Division’s clinical contractor, MedImpact (MI). The primary contact at MI for Mississippi Medicaid is:

Matthew Lennertz, Pharm.D., MS, MBA – Managing Principal, Medicaid PDL and Rebate Strategy

P&T Committee Contacts

Please route inquiries regarding the P&T Committee to the Bureau of Pharmacy to the following.

Phone: (601) 359-5253, option #4